Evidence map›Paper›PMID 37193681›Full record

ArticleCell discovery2023

Deep sampling of gRNA in the human genome and deep-learning-informed prediction of gRNA activities.

Heng Zhang, Jianfeng Yan, Zhike Lu, Yangfan Zhou, Qingfeng Zhang, Tingting Cui, Yini Li, Hui Chen, Lijia Ma

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Facilitating crRNA Design by Integrating DNA Interaction Features of CRISPR-Cas12a System.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Heng Zhang *Center for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Jianfeng Yan *Center for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Zhike Lu *Center for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Yangfan ZhouCenter for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-6726-0523
Qingfeng ZhangAIdit Therapeutics, Hangzhou, Zhejiang, China.
Tingting CuiAIdit Therapeutics, Hangzhou, Zhejiang, China.
Yini LiCenter for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Hui ChenAIdit Therapeutics, Hangzhou, Zhejiang, China.
Lijia MaCenter for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. malijia@westlake.edu.cn.ORCID http://orcid.org/0000-0001-8592-8139
Westlake University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31950575Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LQ21C060002Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LR21C060001
6 · The paper itself

Abstract

Life science studies involving clustered regularly interspaced short palindromic repeat (CRISPR) editing generally apply the best-performing guide RNA (gRNA) for a gene of interest. Computational models are combined with massive experimental quantification on synthetic gRNA-target libraries to accurately predict gRNA activity and mutational patterns. However, the measurements are inconsistent between studies due to differences in the designs of the gRNA-target pair constructs, and there has not yet been an integrated investigation that concurrently focuses on multiple facets of gRNA capacity. In this study, we analyzed the DNA double-strand break (DSB)-induced repair outcomes and measured SpCas9/gRNA activities at both matched and mismatched locations using 926,476 gRNAs covering 19,111 protein-coding genes and 20,268 non-coding genes. We developed machine learning models to forecast the on-target cleavage efficiency (AIdit_ON), off-target cleavage specificity (AIdit_OFF), and mutational profiles (AIdit_DSB) of SpCas9/gRNA from a uniformly collected and processed dataset by deep sampling and massively quantifying gRNA capabilities in K562 cells. Each of these models exhibited superlative performance in predicting SpCas9/gRNA activities on independent datasets when benchmarked with previous models. A previous unknown parameter was also empirically determined regarding the "sweet spot" in the size of datasets used to establish an effective model to predict gRNA capabilities at a manageable experimental scale. In addition, we observed cell type-specific mutational profiles and were able to link nucleotidylexotransferase as the key factor driving these outcomes. These massive datasets and deep learning algorithms have been implemented into the user-friendly web service http://crispr-aidit.com to evaluate and rank gRNAs for life science studies.

Identifiers

PMID37193681
PMCPMC10188485
OpenAlexW4376871110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.